Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.
about
Lung microbiology and exacerbations in COPDInjectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseasePrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.Host-pathogen interactions: a proteomic view.Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.COPD exacerbations . 2: aetiologyPathogenesis of bacterial exacerbations of COPD.Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.The role of toll-like receptors in acute and chronic lung inflammation.Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD.Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.Role of Inflammatory Risk Factors in the Pathogenesis of
P2860
Q22305860-652346D6-D985-4BDB-8DFB-70CECF66954CQ24236699-7CE4800B-CECF-4263-8C8F-98AB77EBE5C6Q27348844-F9B4B7C1-3B10-4A34-B7F3-1606AA816ADFQ30238816-E554213C-7D64-4A93-8E27-73A4F270651EQ35636112-82EFB58D-E58F-4834-8FDB-38AFB24D399FQ36126463-AE7C2B68-EE22-4826-B1A8-67ACB9698B59Q36146801-920C8DDE-E41D-4237-9B26-B8340F80B37EQ36414253-C8CFD24D-CCC3-4804-A3D6-8F58BCF8E155Q36686865-9F9A7C6C-0D2D-4841-95B4-5AB61F12A704Q37343744-1A8FF6E6-2B45-42B3-AA5B-AA57E577A9B8Q37355837-DCC1C357-064C-450A-A6E0-018A84AC463EQ37812405-3E2A048D-B4F5-4DD0-A164-D23347D2961BQ37814698-422BE736-861D-40BA-BE5B-F28EBAA7D523Q37981768-CFFF6D21-03FE-4906-BFA0-C5AFD0448A05Q38220556-7F9EB275-9273-49FE-966D-266644C9358FQ39200222-8CC70A8D-0660-4E74-A12F-D5762FEFD9DCQ40193602-A9BCF382-48DD-4D3E-8A9B-8412AA0C821EQ40846338-8C4CC1E7-F10A-453D-943F-8FB28FDE8F59Q46971620-1E5EB362-956B-4297-B3D4-48A2AEC195C0Q58586401-4484F576-8090-4FD1-84A3-F8C6C216419F
P2860
Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Host-pathogen interaction duri ...... obstructive pulmonary disease.
@en
type
label
Host-pathogen interaction duri ...... obstructive pulmonary disease.
@en
prefLabel
Host-pathogen interaction duri ...... obstructive pulmonary disease.
@en
P2093
P2860
P1476
Host-pathogen interaction duri ...... obstructive pulmonary disease.
@en
P2093
Evelyn Monninkhof
Marcel Sluijter
Paul van der Valk
Peter W M Hermans
Reshmi Ramdin
Ronald de Groot
P2860
P304
P356
10.1128/IAI.72.2.818-823.2004
P407
P577
2004-02-01T00:00:00Z